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Purpose: To investigate the profile of T-helper type 17 (Th17) cell–related cytokines (interleukin-23 [IL-23], IL-27, IL-17
and interferon-γ [IFN-γ]) in postoperative inflammation in patients with Behcet disease (BD) after cataract surgery.
Methods:  Serum  was  collected  from  seven  BD  patients  with  complicated  cataract,  and  from  nine  controls  with
uncomplicated cataract, before cataract surgery, and again 1, 7, 30, and 90 days after surgery. In addition, aqueous humor
was collected at commencement of surgery. The protein levels of IL-23, IL-27, IL-17, and IFN-γ in the serum and in the
aqueous humor were measured by an enzyme-linked immunosorbent assay. A laser flare-cell photometer was used to
quantify intraocular inflammation.
Results: Serum IL-23, IL-27, and IFN-γ levels were significantly increased after cataract surgery in the BD versus the
control patients. In the BD patients, serum levels of IFN-γ and IL-27 correlated strongly with aqueous flare values and
cell counts. Remarkably, the levels of serum IL-27 were significantly associated with serum IFN-γ levels in BD patients
(r=0.796; p=0.002).
Conclusions: Our data indicates that serum IFN-γ and IL-27 levels are significantly elevated in BD versus control patients
and are strongly associated with post-operative intraocular inflammation.
Behcet disease (BD) is a chronic multisystem disorder
characterized by recurrent uveitis, oral aphthae, genital ulcers,
and skin lesions. Behcet uveitis is one of the most common
types of uveitis occurring in China [1]. Cataract formation, the
most frequent anterior segment complication of uveitis in BD
patients,  is  a  major  cause  of  decreased  visual  acuity  [2].
Treatment  of  these  cataracts  is  not  easy  because  surgical
procedures can provoke inflammation. Suppression of the
inflammatory response is critical for the success of surgery in
these patients.
Although the pathogenesis of BD is still unclear, several
reports suggest that an autoimmune response may play an
important role in the development of inflammation in these
patients [3]. Previous studies have suggested that interferon-
γ (IFN-γ) are present in BD patients [4,5]. Recent studies have
shown increased levels of other T-helper type 17 (Th17) cell
associated  cytokines,  such  as  interleukin  23  (IL-23)  and
IL-17, in BD patients with active uveitis [6]. In addition,
previous studies have shown that the presence of IL-27 may
limit Th17 mediated uveitis [7]. However, the association of
these cytokines with postoperative intraocular inflammatory
activity in BD patients is not yet clear. In this study, we
determine the correlation between the serum concentrations
Correspondence to: Professor Yizhi Liu, State Key Laboratory of
Ophthalmology,  Zhongshan  Ophthalmic  Center,  Sun  Yat-sen
University, Guangzhou 510060, People’s Republic of China; Phone:
(86)20  87330294;  FAX:  (86)  20  87333271;
email: Yizhi_Liu@yahoo.cn
of these cytokines in BD patients and the intraocular variables
of the disease activity.
METHODS
Patients: Seven eyes with complicated cataracts, from seven
BD patients, were included in the study. BD disease was
diagnosed  according  to  the  criteria  determined  by  the
International  Study  Group  for  BD  disease  [1,8].  Cataract
surgery was performed on these patients after at least 3 months
of inactive uveitis. These patients had received prednisone at
a  low  dose  (<20  mg/d),  but  no  other  immunosuppressive
agents, for at least 2 months before the first sampling. Nine
eyes  of  nine  uncomplicated  cataract  patients  (age  related
cataract patients, n=6; congenital cataract patients, n=3) were
selected as controls, were matched for age and sex and the
surgery was performed on the same day as the BD patients.
None  of  these  controls  had  suffered  previous  ophthalmic
disease  or  received  any  medication  known  to  influence
cataract  formation.  Patients  and  controls  underwent
phacoemulsification between July 2008 and March 2009 at
Zhongshan  Ophthalmic  Center  (Guangzhou,  China).  This
study was performed in accordance with the Declaration of
Helsinki and with the approval of the local ethical committee.
Informed consent was obtained from all patients and controls.
Post-operative management: Standard cataract procedure was
performed by the same experienced cataract surgeon (Yizhi
Liu) on all patients as described [9,10]. All patients received
dexamethasone-tobramycin eye drops four times daily during
the first week, and twice a day during the second week, after
which  treatment  was  discontinued  except  when  signs  of
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1425severe postoperative inflammation were present. Patients with
BD disease also received prednisolone (initial dose, 1 mg/kg),
which  was  gradually  reduced,  based  on  the  extent  of
intraocular inflammation.
Measurement of anterior intraocular inflammation: Aqueous
flare measurements and cell counts were made using a slit
lamp and laser flare-cell photometer FC-2000 (Kowa, Tokyo,
Japan) as described in previous studies [9-11]. Measurements
of flare intensity and cell count were done before surgery with
follow-up measurements 1, 7, 30, and 90 days after surgery.
Three individual measurements from each eye were averaged;
measurements affected by artifacts were discarded. Flare and
cell  readings  were  expressed  as  photon  counts  per
millisecond, and cells per 0.5 mm3, respectively.
Sample  collection:  Blood  samples  (2  ml)  were  collected
before surgery and 1, 7, 30, and 90 days after surgery. Samples
of aqueous humor (AqH; 50–100 µl) were collected from the
paracentesis site for phacoemulsification. After centrifugation
at 300× g for 5 min, serum and AqH samples were separated
into cellular components and supernatant and were frozen at
−80 °C until use.
Enzyme-linked immunosorbent assay: The concentrations of
IL-23, IL-27, IL-17, and IFN-γ in sera or AqH were measured
with  commercial  sandwich  enzyme-linked  immunosorbent
assays,  following  the  manufacturer’s  instructions  (DuoSet
ELISA Development System; R&D Systems, Minneapolis,
MN). The limit of detection was 15 pg/ml.
Statistical analysis: The data were analyzed using SPSS 10.0
for Windows XP (SPSS Science, Chicago, IL). All data were
expressed as mean±SD. Variables at the follow-up times were
compared using Student’s t test. Linear regression was used
to assess the influence of potential risk factors (age, sex,
“phaco-time” and “phaco-energy”) on flare values and cell
counts.  Correlation  coefficients  were  calculated  with  the
Spearman  correlation  coefficient  test.  A  p≤0.05  was
considered statistically significant.
RESULTS
General data of the BD patients and control subjects: Patient
demographics and clinical features are summarized in Table
1. Patient ages ranged from 15 to 52 years in the BD disease
group  and  from  17  to  60  years  in  the  control  group.
Preoperative and postoperative courses were uneventful in all
patients.  Other  variables  (such  as  age,  sex,  cataract  type,
phaco-time, phaco-energy and phaco-time × phaco-energy)
were not correlated with flare values, cell counts, and cytokine
levels in the serum and the AqH.
Cytokine levels of BD patients and controls before surgery:
Before surgery, IL-17 was undetectable in the serum of all BD
patients and control subjects. IL-23 was expressed in serum
of  both  BD  patients  and  control  subjects.  The  low
concentrations of IL-27 and IFN-γ were detected in serum of
BD patients. However, IL-27 and IFN-γ were lower than the
detection level in control subjects (Figure 1). AqH samples
were collected at the initiation of cataract surgery, and protein
levels of the Th17-associated cytokines were measured. The
results  showed  that  IL-23,  IL-27,  IL-17,  and  IFN-γ  were
undetectable in all AqH samples of both BD patients and
controls.
The  change  in  cytokine  levels  of  BD  patients  following
surgery: In BD patients, serum IL-23, IFN-γ, and IL-27 levels
significantly increased and peaked on day 1 post-surgery.
Then IFN-γ and IL-27 levels decreased rapidly during the first
week, although IL-23 level still elevated. All these cytokines
gradually returned to preoperative levels by 90 days after
surgery (Figure 2). IL-17 was undetectable in serum of BD
patients after surgery.
TABLE 1. DEMOGRAPHIC AND CLINICAL FEATURES OF BD PATIENTS AND CONTROL SUBJECTS.
Parameters Patients with BD disease Control subjects
n 7 9
Age (y) 36.71±13.78 40.43±11.06
Sex (male/female) 3/4 4/5
Phaco-time (s) 24.43.±16.17 28.15±19.26
Phaco-energy (%) 11.29±3.52 12.37±2.48
Intraocular inflammation Flare value Cell counts Flare value Cell counts
Preoperative 6.07±2.57 0.57±0.34 1.71±1.46 0.22±0.17
Postoperative
1 day 72.71±20.36*** 34.77±9.57*** 23.21±8.34*** 12.40±2.57***
7 d 52.94±14.68*** 20.12±6.81*** 12.96±4.63*** 5.98±2.34***
30 d 12.52±3.51** 2.74±1.40** 2.21±1.45 0.61±0.53*
90 d 5.88±2.30 0.70±0.64 1.81±1.37 0.28±0.19
                *p<0.05; **p<0.01; ***p<0.001 (compared with preoperative levels).
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1426The change in cytokine levels of controls following surgery:
In control subjects, serum IL-23 levels increased on day 1
post-surgery, decreased during the first month, and gently
elevated on day 90 post-surgery. IL-17, IFN-γ, and IL-27 were
still lower than the detection level after surgery (Figure 3).
Comparison  of  cytokine  levels  between  BD  patients  and
controls: Serum IL-23 levels were considerably higher in BD
patients compared to control subjects preoperatively and on
days 1, 7, 30, and 90 days postoperatively (p=0.003, p<0.001,
p<0.001, p<0.001, and p=0.007, respectively; Figure 4).
Significant  correlation  between  serum  levels  of  Th17
cytokines and inflammatory variables in BD patients: The
results showed that, for both groups, the aqueous flare value
and cell count increased after surgery and achieved the highest
level on day 1 post-surgery, and then decreased rapidly during
the first week, which was then followed by a more gradual
reduction. Serum IFN-γ and IL-27 levels correlated strongly
with aqueous flare value and cell counts in BD patients, but
that serum IL-23 levels did not (Table 2 and Figure 5). Of note,
serum  IL-27  levels  in  BD  patients  were  significantly
Figure 1. The cytokine levels (pg/ml) of
BD patients and controls before surgery.
Figure 2. The change in cytokine levels
(pg/ml) of BD patients after surgery.
Figure 3. The change in cytokine levels
(pg/ml) of controls after surgery.
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1427associated with serum IFN-γ levels (r=0.796; p=0.002). No
correlation has been found between serum IL-23 levels and
postoperative  inflammation,  although  serum  IL-23  levels
were elevated after surgery in control subjects.
DISCUSSION
Cataract, resulting from chronic intraocular inflammation or
from the corticosteroid therapy given for inflammation, is a
common  complication  of  uveitis  in  BD  patients.  In  both
children  and  adults,  the  importance  of  preoperative  and
postoperative inflammation control is paramount [12,13]. The
Th17  cell  is  a  unique  CD4-positive  (CD4+)T-cell  subset
characterized by the production of IL-17. Recent data from
humans and mice suggests that Th17 cells play an important
role  in  the  pathogenesis  of  a  diverse  group  of  immune-
mediated diseases, including BD and Vogt-Koyanagi-Harada
(VKH) disease [6,9,14,15]. It has been shown that BD patients
with active uveitis exhibit higher IL-17 and IL-23 levels as
compared  with  patients  with  inactive  uveitis,  or  normal
controls [6].
IL-23, a member of the IL-12 family of cytokines, plays
an important role in Th17 maintenance [16]. In the present
study, we measured the dynamic changes of serum IL-23 in
BD patients and control subjects both before and after surgery.
The results showed that serum IL-23 was upregulated in BD
patients,  compared  with  controls,  both  before  and  after
surgery.  However,  no  statistical  association  was  found
between the increased serum IL-23 levels and intraocular
inflammation in BD patients. The exact role of IL-23  on
postoperative  uveitis  is  not  well  understood  and  further
studies are needed to define this in more detail.
Previous  studies  found  that  an  extremely  Th1-rich
cytokine environment was formed in Behçet uveitis [4,17].
The present study was also done to evaluate the influence of
cataract surgery on IFN-γ expression. Our results showed
significantly upregulated serum levels of IFN-γ after surgery
in BD patients which correlated with inflammatory variables
of  postoperative  uveitis.  These  results  are  consistent  with
those of previous studies that documented that BD patients
with active uveitis showed increased levels of IFN-γ in both
Figure 4. The comparison of cytokine
levels (pg/ml) between BD patients and
controls.
TABLE 2. CORRELATION ANALYSIS OF SERUM CYTOKINE LEVELS AND INFLAMMATORY VARIABLES IN BD PATIENTS.
  Serum IL-23 Serum IFN-γ Serum IL-27
Variables r p r p r p
Flare value 0.214 0.107 0.764 0.013 0.755 0.026
Cell counts 0.549 0.093 0.803 0.002 0.694 0.011
                All correlations were calculated with the Spearman correlation coefficient test.
Figure 5. The correlation between serum
levels of Th17 cytokines (pg/ml) and
inflammatory variables(flare value: pc/
ms;  cell  counts:  cells/0.5mm3)  in  BD
patients.
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1428the serum and the AqH as compared to normal controls [4-6,
14]. Unexpectedly, it has been shown that almost half of all
the Th17 cells co-express IFN-γ in humans, and that IFN-γ
may inhibit IL-17 expression [6,16,18]. The exact relationship
between IL-17 and IFN-γ in postoperative uveitis is not well
understood and further studies are needed to describe this in
more detail.
The immunologic role of IL-27 has been documented and
discussed  in  relation  to  various  Th1/Th17-mediated
inflammatory diseases [19,20]. However, its importance in
postoperative uveitis is unknown. In this study, we invested
the variation in the levels of serum IL-27 before and after
surgery. The results showed that serum IL-27 levels in BD
patients  were  significantly  elevated  after  surgery  and
correlated significantly with disease severity and serum IFN-
γ levels. These findings are consistent with earlier reports
about the cytokine environment in psoriasis [21]. In addition,
it has been shown that IL-27, as constitutively expressed in
retinal ganglion and photoreceptor cells, is upregulated by
IFN-γ, and inhibited Th17 proliferation in uveitis [7]. Thus,
the results of our study indicate that elevated IL-27 in the sera
of  BD  patents  after  surgery  plays  an  important  role  in
postoperative  inflammation.  Further  studies  are  needed  to
assess whether IL-27 plays a protective or pathogenic role in
postoperative uveitis in BD patients.
Although IL-17 was undetectable in the serum of all
subjects in the present study, a previous study found that IL-17
production by CD4+ T cells increased significantly in the
presence of IL-23 in BD patients with active uveitis [6]. In
addition, it was reported that IL-17 is present in active uveitic
eyes in BD patients [4]. However, in our study, IL-23, IL-17,
IL-27, and IFN-γ were undetectable in the AqH of both BD
patients and controls. These results might be attributed to the
inactive stages of inflammation in BD patients, to the use of
topical corticosteroids and to the different assays used for
study.
Our study showed that the serum levels of IL-23, IFN-γ,
and IL-27 were significantly elevated after cataract surgery in
BD patients. These findings support previous reports about
the effects of cataract surgery on age-related cataract patients
and patients with VKH disease [9,22]. A significant increase
of serum levels of cytokines in cataract patients following
cataract surgery, have been described in those studies. In
addition,  serum  cytokines  relating  to  the  activity  of  the
inflammatory response in BD patients were most prominent
in several studies [23,24]. As memory T cells can be potent
inducers of the cytokines tested, the increased serum levels of
IL-23, IFN-γ, and IL-27 following surgery strongly suggest
an  underlying  inflammation  and  immune  hypersensitivity
reaction in patients with BD disease that is provoked by the
cataract  trauma.  These  findings  may  be  associated  with
several factors: a more severe postoperative disturbance of the
blood-aqueous barrier, a greater uveal reaction to surgical
trauma  and  some  systemic  response  triggered  in  the
circulation. Further studies are needed to assess the real role
of these cytokines in postoperative uveitis in BD patients.
In conclusion, this study showed that increased serum
levels of Th17-related cytokines, particularly of IL-27 and
IFN-γ,  are  possibly  involved  in  the  development  of
postoperative inflammation in BD patients. However, given
the  meticulous  cross-regulatory  mechanisms  in  Th17
cytokines, further study is needed to investigate their detailed
role  in  the  postoperative  ocular  inflammation  of  different
aspects of uveitic diseases.
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